Balaji Gandhi is CFO at Phreesia, Inc. (PHR). They have made 22 open-market trades across 1 company since 2023, most recently 2026-09-01.
CIK 0001970527
Unrated. We grade insiders only on stock they chose to buy on the open market. Grants, option exercises and vesting say nothing about timing, so they don't count — which is why someone can file often and still have no grade. It isn't a bad sign: unrated buys beat every graded tier below A.
0 open-market purchases, against 22 sales. Too few scored purchases to measure a record yet.
| Ticker | Shares | Value |
|---|---|---|
| PHR | 348,931 | $4.6M |
Shares reported on the most recent Form 4, priced at the 2026-09-03 close.
Counted per filing, not per execution lot — a purchase filled in several tranches is one decision.
| Ticker | Type | Traded | Filed | Price | Value | 7d Stock | 30d Stock | 90d Stock |
|---|---|---|---|---|---|---|---|---|
| PHR | SELL | 2026-03-25 | 2026-03-27 | $11.26 | $86K | -26.5% | -12.5% | -17.1% |
| PHR | SELL | 2026-01-15 | 2026-01-20 | $16.36 | $93K | -15.2% | -20.5% | -40.4% |
| PHR | SELL | 2026-01-08 | 2026-01-12 | $17.01 | $136K | -7.3% | -26.9% | -49.9% |
| PHR | SELL | 2025-10-17 | 2025-10-21 | $22.36 | $20K | -2.6% | -18.1% | -32.3% |
| PHR | SELL | 2025-09-16 | 2025-09-18 | $23.28 | $195K | -3.1% | -5.4% | -32.8% |
| PHR | SELL · 10b5-1 | 2025-08-25 | 2025-08-27 | $30.01 | $575K | -16.2% | -25.5% | -35.0% |
| PHR | SELL | 2025-07-17 | 2025-07-21 | $26.89 | $24K | +1.6% | +4.4% | -13.6% |
| PHR | SELL | 2025-04-16 | 2025-04-17 | $23.81 | $21K | +5.3% | +7.1% | +14.0% |
| PHR | SELL | 2025-04-08 | 2025-04-10 | $23.86 | $384K | +2.9% | +10.9% | +23.2% |
| PHR | SELL | 2025-03-26 | 2025-03-28 | $27.46 | $100K | -0.1% | -2.9% | +10.8% |
| PHR | SELL · 10b5-1 | 2025-02-18 | 2025-02-20 | $30.04 | $350K | -11.1% | -2.0% | -14.5% |
| PHR | SELL · 10b5-1 | 2025-02-13 | 2025-02-18 | $30.02 | $1.2M | -9.5% | -5.8% | -13.3% |
| PHR | SELL | 2025-01-27 | 2025-01-29 | $27.35 | $224K | +0.5% | -8.0% | -13.8% |
| PHR | SELL | 2025-01-21 | 2025-01-22 | $27.31 | $318K | +4.8% | +5.2% | -13.2% |
| PHR | SELL | 2025-01-15 | 2025-01-17 | $26.98 | $23K | +4.9% | +8.5% | -13.3% |
| PHR | SELL | 2025-01-06 | 2025-01-08 | $26.61 | $170K | -2.3% | +4.1% | -15.0% |
| PHR | SELL | 2024-10-15 | 2024-10-17 | $21.03 | $18K | -10.4% | -8.2% | +32.3% |
| PHR | SELL | 2024-09-10 | 2024-09-12 | $23.25 | $163K | -4.5% | -12.5% | +3.1% |
| PHR | SELL | 2024-07-16 | 2024-07-17 | $23.74 | $19K | +1.4% | -0.1% | -13.4% |
| PHR | SELL | 2024-04-15 | 2024-04-17 | $22.86 | $22K | -9.9% | +5.1% | +5.3% |
| PHR | SELL | 2024-04-08 | 2024-04-10 | $22.62 | $176K | -3.2% | -7.7% | -12.6% |
| PHR | SELL | 2024-03-25 | 2024-03-27 | $23.21 | $163K | -1.9% | -14.8% | -11.6% |
| PHR | SELL | 2024-01-16 | 2024-01-18 | $24.14 | $466K | +3.4% | +4.1% | -6.5% |
| PHR | SELL | 2023-10-16 | 2023-10-17 | $16.61 | $14K | -25.1% | -6.0% | +48.7% |
| PHR | SELL | 2023-09-13 | 2023-09-14 | $20.32 | $158K | -12.0% | -18.3% | +4.9% |
Grouped by shared companies and similar filing behaviour. This is a similarity measure, not a ranking or a performance signal.